tradmap

QTRX Quanterix Corp

$2.57 -1.91%

Updated

Healthcare · Laboratory Analytical Instruments

Quanterix Corp (QTRX) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $122 million. Shares last traded at $2.57, 70.7% below their 52-week high. Over the past year the stock is down 40.9%. Net profit margin is -80.2%, below the peer median of -1.7%. Revenue grew 1.1% year over year.

Market Cap
$122M
Shares Out
47.3M
EPS (TTM)
$-5.12
P/E Ratio
P/S Ratio
0.79
P/B Ratio
0.51
Dividend / Share
Dividend Yield
52-Week High
$8.77
52-Week Low
$2.15
Volume
26,884
Avg Vol (3m)
60,954.984

Performance

1W
-2.65%
1M
-31.65%
3M
-32.19%
6M
-51.51%
YTD
-60.09%
1Y
-40.92%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
38.77
SMA (50)
$3.48
SMA (200)
$4.64
Price vs SMA50
-26.18%
Price vs SMA200
-44.60%
ATR (14)
$0.25

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$153M
Net Income
$-123M
Gross Margin
42.7%
Operating Margin
-99.6%
Net Margin
-80.2%
Return on Equity
-51.9%
Return on Assets
-38.5%
Current Ratio
3.40
Debt / Equity
0.01
Revenue Growth (YoY)
+1.1%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-1.41 2026-08-10
Q1 2026 $-0.37 2026-05-06
FY 2025 $-2.51 2026-03-02
Q3 2025 $-2.04 2025-11-10
Q2 2026 $-1.30 2026-08-10
Q1 2026 $-0.53 2026-05-06

Full earnings history →

Laboratory Analytical Instruments peers

QTRX vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated

P/S vs peers
0.79 / 5.01 med
-84% discount
Net margin vs peers
-80.2% / -1.7% med
below median
1–14 of 14
AAgilent Technologies$42.3B29.355.7319.5%-0.93%
WATWaters Corporation$40.6B63.248.7513.8%+0.36%
ILMNIllumina, Inc.$33.5B40.587.4518.4%+3.90%
MTDMettler Toledo$27.2B30.016.5821.9%-0.77%
RVTYRevvity$14.6B61.375.018.2%-0.24%
BIOBio-Rad Laboratories, Inc.$10.4B46.814.028.6%-0.19%
AVTRAvantor, Inc.$10.4B-18.811.58-8.4%+3.65%
BRKRBruker Corp$9.1B-127.122.59-2.0%+0.61%
TXG10x Genomics, Inc.$8.2B-108.5013.21-12.2%+2.45%
ALMRAlamar Biosciences, Inc.$2.1B+0.51%
CTKBCytek Biosciences, Inc.$611M-9.182.96-32.2%+0.21%
MASS908 Devices Inc.$414M-11.956.81-57.0%-3.05%
PACBPacific Biosciences Of California, Inc.$403M-3.06-1.52%
EYPTEyepoint, Inc.$394M-1.28-4.39%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.